- Home
- SVRA vs UAMY Comparison
SVRA vs UAMY Comparison
Compare SVRA & UAMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SVRA | UAMY |
|---|---|---|
| Founded | 2007 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 955.8M |
| IPO Year | 2009 | 1997 |
Fundamental Metrics
Financial Performance| Metric | SVRA | UAMY |
|---|---|---|
| Price | $5.33 | $4.92 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 5 |
| Target Price | $7.33 | ★ $9.44 |
| AVG Volume (30 Days) | 1.4M | ★ 7.6M |
| Earning Date | 05-13-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $39,257,708.00 |
| Revenue This Year | N/A | $219.89 |
| Revenue Next Year | $430.87 | $104.28 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 162.80 |
| 52 Week Low | $3.34 | $4.36 |
| 52 Week High | $7.01 | $19.71 |
Technical Indicators
Market Signals| Indicator | SVRA | UAMY |
|---|---|---|
| Relative Strength Index (RSI) | 44.30 | 44.30 |
| Support Level | $5.16 | $4.76 |
| Resistance Level | $5.43 | $5.78 |
| Average True Range (ATR) | 0.20 | 0.36 |
| MACD | -0.00 | 0.04 |
| Stochastic Oscillator | 17.65 | 36.33 |
Price Performance
Historical ComparisonAbout SVRA Savara Inc.
Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).
About UAMY United States Antimony Corporation
United States Antimony Corp is a fully integrated mining, transportation, milling, smelting, and selling company. It has two operating segments: antimony and zeolite. Its products and services include antimony; silver; gold; zeolite products; and storage, handling, & packaging services. The company's geographical segments are the Domestic, Canada, and Mexico, of which the vast majority of its revenue comes from the Domestic.